Wedbush Securities
FBT icon

Wedbush Securities’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Wedbush Securities’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$209K Sell
769
-100
-12% -$26K 0.01% 1180
2026
Q2 		$215K Sell
869
-136
-14% -$29.3K 0.01% 1171
2026
Q1 		$202K Sell
1,005
-81
-7% -$16.8K 0.01% 1131
2025
Q4 		$224K Buy
+1,086
New +$217K 0.01% 1044
2022
Q1 		– Sell
-1,384
Closed -$224K – 1133
2021
Q4 		$224K Hold
1,384
– – 0.01% 1008
2021
Q3 		$230K Sell
1,384
-127
-8% -$21.7K 0.01% 995
2021
Q2 		$261K Sell
1,511
-190
-11% -$31.4K 0.01% 927
2021
Q1 		$273K Buy
1,701
+118
+7% +$20.2K 0.02% 852
2020
Q4 		$266K Sell
1,583
-22
-1% -$3.57K 0.02% 689
2020
Q3 		$252K Sell
1,605
-520
-24% -$85K 0.02% 691
2020
Q2 		$357K Buy
2,125
+500
+31% +$78.5K 0.03% 542
2020
Q1 		$213K Sell
1,625
-45
-3% -$6.41K 0.03% 664
2019
Q4 		$248K Sell
1,670
-239
-13% -$32.8K 0.02% 753
2019
Q3 		$236K Sell
1,909
-200
-9% -$26.6K 0.02% 754
2019
Q2 		$297K Buy
2,109
+442
+27% +$61K 0.03% 632
2019
Q1 		$251K Buy
+1,667
New +$240K 0.03% 670
2018
Q4 		– Sell
-1,268
Closed -$201K – 866
2018
Q3 		$201K Buy
+1,268
New +$192K 0.02% 778
2016
Q4 		– Sell
-3,951
Closed -$394K – 838
2016
Q3 		$394K Sell
3,951
-305
-7% -$29.9K 0.06% 406
2016
Q2 		$381K Sell
4,256
-140
-3% -$12.9K 0.06% 362
2016
Q1 		$385K Sell
4,396
-2,188
-33% -$193K 0.07% 326
2015
Q4 		$744K Buy
6,584
+46
+0.7% +$4.95K 0.13% 171
2015
Q3 		$662K Sell
6,538
-1,338
-17% -$159K 0.13% 175
2015
Q2 		$977K Buy
7,876
+856
+12% +$103K 0.18% 129
2015
Q1 		$830K Buy
7,020
+1,862
+36% +$211K 0.14% 161
2014
Q4 		$526K Sell
5,158
-214
-4% -$20.9K 0.08% 254
2014
Q3 		$493K Buy
5,372
+662
+14% +$57.4K 0.08% 268
2014
Q2 		$388K Buy
4,710
+195
+4% +$14.9K 0.06% 321
2014
Q1 		$346K Buy
4,515
+377
+9% +$29.4K 0.06% 325
2013
Q4 		$286K Buy
4,138
+575
+16% +$37.7K 0.07% 350
2013
Q3 		$231K Buy
+3,563
New +$225K 0.06% 381

Other funds holding FBT

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Hartford Financial Management
Hartford Financial Management Hartford, Connecticut $448M AUM 24.02% 1-Year Est. Return
Arlington Financial Advisors
Arlington Financial Advisors Santa Barbara, California $796M AUM 16.35% 1-Year Est. Return
B. Riley Wealth Advisors
B. Riley Wealth Advisors Boca Raton, Florida $2.57B AUM 28.13% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Concurrent Investment Advisors
Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
TriaGen Wealth Management
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
Ocean Park Asset Management
Ocean Park Asset Management Santa Monica, California $1.65B AUM 1.83% 1-Year Est. Return

Wedbush Securities's FBT Position: Q3 2026 in Review

Wedbush Securities reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 12% in Q3 2026, selling an estimated $26K and leaving 769 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #1180.

Wedbush Securities first reported a position in FBT in Q3 2013 and has held it in 30 quarters since. The position peaked at $977K in Q2 2015. 98 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Wedbush Securities held 769 shares of First Trust NYSE Arca Biotechnology Index Fund worth $209K as of Q3 2026.
  • Wedbush Securities sold 100 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $26K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Wedbush Securities's portfolio in Q3 2026, its #1180 holding.
  • Wedbush Securities first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2013 and has held it in 30 quarters since.
  • Wedbush Securities's First Trust NYSE Arca Biotechnology Index Fund position peaked at $977K in Q2 2015.
  • 98 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Wedbush Securities's 13F filing for Q3 2026, filed 22 Oct 2026.